456 related articles for article (PubMed ID: 24385403)
1. Prognostic and predictive biomarkers: tools in personalized oncology.
Nalejska E; Mączyńska E; Lewandowska MA
Mol Diagn Ther; 2014 Jun; 18(3):273-84. PubMed ID: 24385403
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
3. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
4. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
[TBL] [Abstract][Full Text] [Related]
5. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology as a tool for the treatment of cancer.
de Castro Sant' Anna C; Junior AGF; Soares P; Tuji F; Paschoal E; Chaves LC; Burbano RR
Clin Exp Med; 2018 Nov; 18(4):457-464. PubMed ID: 30006681
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
Donovan MJ; Cordon-Cardo C
Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
[TBL] [Abstract][Full Text] [Related]
8. An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers.
Robles AI; Arai E; Mathé EA; Okayama H; Schetter AJ; Brown D; Petersen D; Bowman ED; Noro R; Welsh JA; Edelman DC; Stevenson HS; Wang Y; Tsuchiya N; Kohno T; Skaug V; Mollerup S; Haugen A; Meltzer PS; Yokota J; Kanai Y; Harris CC
J Thorac Oncol; 2015 Jul; 10(7):1037-48. PubMed ID: 26134223
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
10. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnostics and personalized medicine in oncology: challenges and opportunities.
Normanno N; Rachiglio AM; Roma C; Fenizia F; Esposito C; Pasquale R; La Porta ML; Iannaccone A; Micheli F; Santangelo M; Bergantino F; Costantini S; De Luca A
J Cell Biochem; 2013 Mar; 114(3):514-24. PubMed ID: 22991232
[TBL] [Abstract][Full Text] [Related]
12. Molecular Biomarkers in Cancer.
Sarhadi VK; Armengol G
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 35892331
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of circulating tumor cells in immunotherapy.
Rzhevskiy A; Kapitannikova A; Malinina P; Volovetsky A; Aboulkheyr Es H; Kulasinghe A; Thiery JP; Maslennikova A; Zvyagin AV; Ebrahimi Warkiani M
Theranostics; 2021; 11(16):8057-8075. PubMed ID: 34335980
[TBL] [Abstract][Full Text] [Related]
15. SNPs in microRNA binding sites as prognostic and predictive cancer biomarkers.
Preskill C; Weidhaas JB
Crit Rev Oncog; 2013; 18(4):327-40. PubMed ID: 23614619
[TBL] [Abstract][Full Text] [Related]
16. Tumour biomarkers-Tracing the molecular function and clinical implication.
Lin J; Ma L; Zhang D; Gao J; Jin Y; Han Z; Lin D
Cell Prolif; 2019 May; 52(3):e12589. PubMed ID: 30873683
[TBL] [Abstract][Full Text] [Related]
17. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
[TBL] [Abstract][Full Text] [Related]
18. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
Schmidt KT; Chau CH; Price DK; Figg WD
J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
[TBL] [Abstract][Full Text] [Related]
19. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
Saumet A; Lecellier CH
Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
[TBL] [Abstract][Full Text] [Related]
20. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia.
Long L; Assaraf YG; Lei ZN; Peng H; Yang L; Chen ZS; Ren S
Drug Resist Updat; 2020 Sep; 52():100703. PubMed ID: 32599434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]